Differential properties of E prostanoid receptor-3 and thromboxane prostanoid receptor in activation by prostacyclin to evoke vasoconstrictor response in the mouse renal vasculature
- PMID: 33047360
- DOI: 10.1096/fj.202000845RR
Differential properties of E prostanoid receptor-3 and thromboxane prostanoid receptor in activation by prostacyclin to evoke vasoconstrictor response in the mouse renal vasculature
Abstract
Vasomotor reactions of prostacyclin (prostaglandin I2 ; PGI2 ) can be collectively modulated by thromboxane prostanoid receptor (TP), E-prostanoid receptor-3 (EP3), and the vasodilator I prostanoid receptor (IP). This study aimed to determine the direct effect of PGI2 on renal arteries and/or the whole renal vasculature and how each of these receptors is involved. Experiments were performed on vessels or perfused kidneys of wild-type mice and/or mice with deficiency in TP (TP-/- ) and/or EP3. Here we show that PGI2 did not evoke relaxation, but instead resulted in contraction of main renal arteries (from ~0.001-0.01 µM) or reduction of flow in perfused kidneys (from ~1 µM); either of them was reversed into a dilator response in TP-/- /EP3-/- counterparts. Also, we found that in renal arteries although it has a lesser effect than TP-/- on the maximal contraction to PGI2 (10 µM), EP3-/- but not TP-/- resulted in relaxation to the prostanoid at 0.01-1 µM. Meanwhile, TP-/- only significantly reduced the contractile activity evoked by PGI2 at ≥0.1 µM. These results demonstrate that PGI2 may evoke an overall vasoconstrictor response in the mouse renal vasculature, reflecting activities of TP and EP3 outweighing that of the vasodilator IP. Also, our results suggest that EP3, on which PGI2 can have a potency similar to that on IP, plays a major role in the vasoconstrictor effect of the prostanoid of low concentrations (≤1 µM), while TP, on which PGI2 has a lower potency but higher efficacy, accounts for a larger part of its maximal contractile activity.
Keywords: EP3; IP; PGI2; TP; renal vasoresponse.
© 2020 Federation of American Societies for Experimental Biology.
Similar articles
-
Prostaglandin E2 sequentially activates E-prostanoid receptor-3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature.FASEB J. 2020 Feb;34(2):2568-2578. doi: 10.1096/fj.201901611R. Epub 2019 Dec 18. FASEB J. 2020. PMID: 31908041
-
Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice.Sci Rep. 2017 Feb 6;7:42167. doi: 10.1038/srep42167. Sci Rep. 2017. PMID: 28165064 Free PMC article.
-
The vasoconstrictor activities of prostaglandin D2 via the thromboxane prostanoid receptor and E prostanoid receptor-3 outweigh its concurrent vasodepressor effect mainly through D prostanoid receptor-1 ex vivo and in vivo.Eur J Pharmacol. 2023 Oct 5;956:175963. doi: 10.1016/j.ejphar.2023.175963. Epub 2023 Aug 3. Eur J Pharmacol. 2023. PMID: 37543159
-
Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension.Trends Pharmacol Sci. 2017 Jun;38(6):512-523. doi: 10.1016/j.tips.2017.03.003. Epub 2017 Apr 12. Trends Pharmacol Sci. 2017. PMID: 28412042 Review.
-
Vasoconstrictor prostanoids.Pflugers Arch. 2010 May;459(6):941-50. doi: 10.1007/s00424-010-0812-6. Epub 2010 Mar 24. Pflugers Arch. 2010. PMID: 20333529 Review.
References
REFERENCE
-
- Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976;12:897-913.
-
- Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997-1029.
-
- Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79:1193-1226.
-
- Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-182.
-
- Davidge ST. Prostaglandin H synthase and vascular function. Circ Res. 2001;89:650-660.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources